Literature DB >> 16642029

Effect of BMP-2 gene transfer on bone healing in sheep.

M Egermann1, C A Lill, K Griesbeck, C H Evans, P D Robbins, E Schneider, A W Baltzer.   

Abstract

Critical size defects of bone and delayed fracture healing due to metabolic disorders are still problems in orthopaedic surgery. Adenoviral vectors encoding bone morphogenetic protein-2 (Ad.BMP-2) have been used to stimulate bone formation in small animals. The present study evaluated the use of direct adenoviral gene transfer for inducing bone formation in a large animal. Standardized iliac crest defects were created surgically on both sides of the pelvic bone of white mountain sheep. The efficiency of gene transfer was evaluated using recombinant adenoviruses carrying the cDNA for luciferase. High levels of transgene expression, restricted to the site of injection, were found for the 1st week. Transgene expression then fell considerably, but could still be detected for up to 5 weeks. To investigate the effect on bone healing, Ad.BMP-2 (10(11) particles in 200 mul saline) was unilaterally injected into iliac crest defects and into tibial osteotomies. The contralateral defects remained untreated to evaluate possible systemic effects. The controls were treated with saline solution. Bone formation within the defect, assessed by micro-computed tomography (CT) measurement at 8 weeks, and callus formation after osteotomy were significantly reduced following direct application of Ad.BMP-2. The retardation compared to untreated control animals was additionally found at the contralateral iliac crest indicating a systemic inhibitory effect. Histological analysis confirmed the CT measurement and showed an increased number of inflammatory cells within both defects. Antibodies against the adenovirus and the transgene product were detected in all treated animals. These data show a systemic retardation of bone formation following a single local injection of Ad.BMP-2 in sheep. This finding stands in contrast to the data obtained from small animal models. Further studies are needed to determine the contribution of the immune response to these results, and whether a lower dose of Ad.BMP-2 would be advantageous.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642029     DOI: 10.1038/sj.gt.3302785

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  30 in total

1.  Tribute to Dr. Marshall Urist: musculoskeletal growth factors: editorial comment.

Authors:  Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

Review 2.  Cell-free and cell-based approaches for bone regeneration.

Authors:  Ericka M Bueno; Julie Glowacki
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

Review 3.  Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.

Authors:  Gadi Pelled; Ayelet Ben-Arav; Colleen Hock; David G Reynolds; Cemal Yazici; Yoram Zilberman; Zulma Gazit; Hani Awad; Dan Gazit; Edward M Schwarz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 4.  Gene therapy approaches to regenerating bone.

Authors:  Nadav Kimelman Bleich; Ilan Kallai; Jay R Lieberman; Edward M Schwarz; Gadi Pelled; Dan Gazit
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 5.  Gene therapy for the regeneration of bone.

Authors:  Christopher Evans
Journal:  Injury       Date:  2011-04-13       Impact factor: 2.586

Review 6.  Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures.

Authors:  Amin Bigham-Sadegh; Ahmad Oryan
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

Review 7.  BMP gene delivery for skeletal tissue regeneration.

Authors:  Maxim Bez; Gadi Pelled; Dan Gazit
Journal:  Bone       Date:  2020-05-21       Impact factor: 4.398

8.  In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs.

Authors:  Maxim Bez; Dmitriy Sheyn; Wafa Tawackoli; Pablo Avalos; Galina Shapiro; Joseph C Giaconi; Xiaoyu Da; Shiran Ben David; Jayne Gavrity; Hani A Awad; Hyun W Bae; Eric J Ley; Thomas J Kremen; Zulma Gazit; Katherine W Ferrara; Gadi Pelled; Dan Gazit
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

9.  Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle.

Authors:  F Liu; E Ferreira; R M Porter; V Glatt; M Schinhan; Z Shen; M A Randolph; C A Kirker-Head; C Wehling; M S Vrahas; C H Evans; J W Wells
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

10.  Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.

Authors:  Hidenori Matsubara; Hiroyuki Tsuchiya; Koji Watanabe; Akihiko Takeuchi; Katsuro Tomita
Journal:  Clin Orthop Relat Res       Date:  2008-09-24       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.